The Week Ahead In Biotech: PDUFA Dates, IPOs And More
Here's a few must-watch biotech catalysts this week. Conferences Panamerican League of Associations for Rheumatology Congress – April 7-11 at Hotel Hilton, Buenos Aires, Argentina. read more.....»»
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Results
Biotech stocks saw a resurgence this week, as a post-earnings follow-up rally and company-specific news offered support. The iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) gained about 1.5 percent. The followi.....»»
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings
The biotech .....»»
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings
The biotech sector notched strong gains last week, capitalizing on the positive overall mark.....»»
The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates
Despite Friday's recovery, biotech stocks continued to hemorrhage last week following declines two weeks of declines. read more.....»»
The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates
Despite Friday's recovery.....»»
The Week Ahead In Biotech: ASH 2018, PDUFA Dates, Clinical Trials And Earnings
Notwithstanding the scanty news flow, biotech stocks came under intense s.....»»
The Week Ahead In Biotech: ASH 2018, PDUFA Dates, Clinical Trials And Earnings
Notwithstanding the s.....»»
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials
Biotech stocks held steady in the recent week as earnings from the sector continue to trickle in. The week also saw presentations of clinical t.....»»
The Week Ahead In Biotech: Johnson & Johnson, Biogen Earnings, Neurology Conference And IPOs
Biotech stocks reversed course in the week ended April 16, with the sector re.....»»
The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight
Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vaccine updates, M&A activity, IPO news flow and follow-on offerings all served to lift stocks higher. read more.....»»
The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight
Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vac.....»»
The Week Ahead In Biotech: 2 IPOs Plus FDA Decisions On Moderna"s COVID Vaccine And Drugs From Amgen, MacroGenics
Biotech stocks advanced for a third straight week, defying the broader market weakness. The space got solid support from positive stock reactions to presentations made at hematology and breast cancer conferences. read more.....»»
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
The smid-cap biotech .....»»
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB) gained about 6% for the week. read more.....»»
Week Ahead In Biotech: PDUFA Date Ahead For Astra Zeneca, Merck"s Lynparza, Pending Clinical Readouts In Focus
Biotech stocks advanced in the penultimate week of the year, and the iSha.....»»
The Week Ahead In Biotech: Pfenex And Clinuvel On The Radar Ahead of FDA Decisions, 2 IPOs On Deck
Notwithstanding the ESMO conference generating some huge moves in some stocks, last week turned out to be a muted one for biotechs. read more.....»»
The Week Ahead In Biotech (Sept. 29-Oct. 5): Conference Presentations, IPOs Hit Top Gear
Biotech stocks came under selling pressure in the week ended Sept. 27 amid clinical data readouts and a handful of FDA decisions. read more.....»»
The Week Ahead In Biotech: Novo Nordisk And Merck Await FDA Rulings, 2 IPOs On Deck
Biotech stocks rebounded in last week after declining modestly in the previous week. read more.....»»
U.S. IPO Week Ahead: A Biotech Wave Drives 7 IPOs While Slack Targets A Direct Listing
U.S. IPO Week Ahead: A Biotech Wave Drives 7 IPOs While Slack Targets A Direct Listing.....»»
The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs
Biotech stocks are on track to extend their losses, bucking the positive broader market sentiment. The week saw Achaogen Inc (NASDAQ: AKAO) filing for Chapter 11 bankruptcy and negative clinical readouts .....»»